Antibiotic susceptibility of clinical isolates of Campylobacter jejuni and Campylobacter coli in Ontario, Canada during 2011-2013

Diagnostic Microbiology and Infectious Disease
Andrew RileySamir N Patel

Abstract

A total of 219 clinical isolates of Campylobacter spp. including 180 Campylobacter jejuni and 39 Campylobacter coli were assessed for in vitro antimicrobial susceptibility. Resistance among C. coli was higher for ciprofloxacin (41% versus 30.80%), erythromycin (12.80% versus 3.90%) and lower for tetracycline (53.80% versus 64.60%) compared to C. jejuni.

References

Aug 1, 1994·Journal of Comparative Pathology·M B Skirrow
Apr 3, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·B M Allos
May 13, 2009·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Kamil BostanMine Kücüker Ang
Dec 22, 2010·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Todd F Hatchette, Dana Farina
May 30, 2012·Critical Reviews in Microbiology·Ahmet Koluman, Abdullah Dikici
Jun 15, 2013·Emerging Infectious Diseases·Agnes AgunosLucie Dutil

❮ Previous
Next ❯

Citations

Apr 18, 2018·Transboundary and Emerging Diseases·I HanssonE O Engvall
Jul 20, 2018·Microbial Genomics·Emma L SprostonSamuel K Sheppard
Dec 13, 2018·Journal of Medical Microbiology·Tuba KaymanOrhan Şahin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Campylobacteriosis (ASM)

Campylobacteriosis is caused by the bacteria Campylobacter jejuni and is a common cause of gastroenteritis in humans. Discover the latest research on Campylobacteriosis here.